Abstract
Our study belongs to the clinical trials in which the health-related quality of life (HQL) evaluation constitutes the primary endpoint. It was carried out with the aim of comparing the impact of three different types of psychological intervention, namely a psychopharmacological treatment alone, the same treatment plus social support carried out by volunteers (SSV) and a third treatment modality including “structured psychotherapy” (autogenous training), on improving the HQL of elderly cancer patients undergoing antineoplastic therapy with symptoms of anxiety and/or depression related to their disease. The eight questionnaires used for HQL evaluation were generally. self-rated and multidimensional but unidimensional models were also employed. Seventy-four patients aged over 65 years with either solid tumors in different sites or hematological malignancies, generally in advanced stages (III–IV), were enrolled in the study. Of these patients, 72 (42 men and 30 women, mean age 70.68 years, range 66–85) were evaluable. Our study high-lighted the usefulness of the pharmacological therapy (alprazolam + sulpiride) and of other specific ancillary treatments in reducing the incidence of the main HQL-related side-effects of antineoplastic therapy and the superiority of an “integrated” strategy, based both on psychopharmacology and psychosocial interventions, such as SSV with or without structured psychotherapy. The one-way analysis of variance carried out by us did not allow us to draw definitive conclusions about which of the two integrated treatments was to be considered the treatment of choice, as they proved to be almost equally effective.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Aaronson NK, Beckman J (1987) The quality of life of cancer patients. (Monograph series of the European Organization for Research on Treatment of Cancer, vol 17) Raven Press, New York
American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd edn, revised. American Psychiatric Association, Washington, DC
Andrykowski MA, Jacobsen P (1993) Anticipatory nausea and vomiting with cancer chemotherapy. In: Breitbart W, Holland JC (eds) Psychiatric aspects of symptom management in cancer patients. American Psychiatric Press, Washington London, pp 107–128
Barofsky I, Sugarbaker PH (1990) Cancer. In: Spilker B (ed) Quality of life assessments in clinical trials. Raven Press, New York, pp 419–439
Beck AT, Beamesderfer A (1974) Assessment of depression, in psychological measurements in psychopharmacology. In: Pichot P (ed) Modern problems in pharmacopsychiatry, vol 7. Karger, Basel, pp 151–169
Bloom JR (1982) Social support, accomodation to stress and adjustment to breast cancer. Soc Sci Med 16:1329–1338
Breitbart W, Passik S (1993) Psychiatric approaches to cancer pain management. In: Breitbart W, Holland JC (eds) Psychiatric aspects of symptom management in cancer patients. American Psychiatric Press, Washington London, pp 49–86
Carta MG, Carpiniello B, Cicone V, Sannais C, Paulis M, Rudas N (1993) Standardization of a psychiatric screening test for use by general practitioners in Sardinia. Preliminary results. Acta Psychiatr Scand 87:342–344
Cella DF, Tulsky DS (1990) Measuring quality of life today: methodological aspects. Oncology 4:29–38
Costa D, Mogos I, Toma T (1985) Efficacy and safety of mianserin in the treatment of depression of women with cancer. Acta Psychiatr Scand 72:85–92
Cull A (1990) Psychological aspects of cancer and chemotherapy. J Psychosom Res 34:129–140
Donovan K, Sanson-Fisher RW, Redman S (1989) Measuring quality of life in cancer patients. J Clin Oncol 7:959–968
Dowie J, Elstein A (1988) Professional judgment: a reader in clinical decision making. Cambridge University Press, Cambridge
Fayers PM, Jones DR (1983) Measuring and analysing quality of life in cancer clinical trials: a review. Statist Med 2:429–446
Fernandez F, Adams F, Holmes VF (1987) Analgesic effect of alprazolam in patients with chronic, organic pain of malignant origin. J Clin Psychopharmacol 3:167–169
Fernandez C, Rosell R, Abad-Esteve A, Monras P, Moreno I, Serichol M, Roviralta M (1989) Quality of life during chemotherapy in non-small cell lung cancer patients. Acta Oncol 28:29–33
Felting JH (1988) Evaluating quality and quantity of life in breast cancer adjuvant trials. J Clin Oncol 6:1795–1797
Filiberti A (1990) Strumenti di valutazione multidimensionale della qualita di vita. In: Tamburini M (ed) La valutazione della qualità di vita in oncologia. Masson, Milan, pp 161–173
Forester B, Kornfeld DS, Fleiss JL (1985) Psychotherapy during radiotherapy: effects on emotional and physical distress. Am J Psychiatry 142:22–27
Forester B, Kornfeld DS, Fleiss JL, Thompson S (1993) Group psychotherapy during radiotherapy: effects on emotional and physical distress. Am J Psychiatry 150:1700–1706
Gotay CC, Korn EL, McCabe MS, Moore TD, Cheson BD (1992) Quality-of-life assessment in cancer treatment protocols: research issues in protocol development. J Natl Cancer Inst 84:575–579
Greenberg DD, Surman OW, Clarke J, Baer L (1987) Alprazolam for phobic nausea and vomiting related to cancer chemotherapy. Cancer Treat Rep 71:549–550
Harding TW, De Arango MV, Balthazar J, et al (1980) Mental disorders in primary health care: a study of their frequency and diagnosis in four developing countries. Psychol Med 10:231–241
Heim E, Augustiny KF, Blaser A, et al (1987) Coping with breast cancer - a longitudinal prospective study. Psychother Psychosom 48:44–59
Holland JC, Morrow GR, Schmale A, et al (1991) A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms. J Clin Oncol 9:1004–1011
Horowitz S, Breitbart W (1993) Relaxation and imagery for symptom control in cancer patients. In: Breitbart W, Holland JC (eds) Psychiatric aspects of symptom management in cancer patients. American Psychiatric Press, Washington London, pp 147–171
House JS (1981) Work, stress and social support. Addison Wesley, Philippines
Kahn R, Antonucci T (1980) Convoys over the life course: attachment, roles and social support. In: Baltes PB, Brim O (eds) Life-span development and behaviour. Lexington Press, Boston
Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH (1948) The use of nitrogen mustards in the palliative treatment of carcinoma with particular reference to bronchogenic carcinoma. Cancer 1:634–656
Kearsley JH, Williams AM, Fiumara AM (1989) Antiemetic superiority of lorazepam over oxazepam and me thylprednisolone as premedicants for patients receiving cisplatin-containing chemotherapy. Cancer 64:1595–1599
Luthe W (1970) Autogenic therapy — dynamics of autogenic neutralization. Grune & Stratton, New York
Luthe W (1973) Autogenic therapy — treatment with autogenic neutralization. Grune & Stratton, New York
Manos N, Christakis J (1985) Coping with cancer: psychological dimensions. Acta Psychiatr Scand 72:1–5
Massie MJ, Shakin EJ (1993) Management of depression and anxiety in cancer patients. In: Breitbart W, Holland JC (eds) Psychiatric aspects of symptom management in cancer patients. American Psychiatric Press, Washington London, pp 1–21
Moinpour CM, Feigl P, Metch B, et al (1989) Quality of life endpoints in cancer clinical trials: review and recommendations. J Natl Cancer Inst 81:485–495
Monfardini S, Yancik RM (1993) Cancer and aging. Meeting the challenges of an aging population. J Natl Cancer Inst 85:532–539
Mor V, Laliberte L, Morris JN, Wiemann M (1984) The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting. Cancer 53:2002–2007
Mori K, Saito Y, Tominaga K (1993) Antiemetic efficacy of alprazolam in the combination of metoclopramide plus methylprednisolone. Am J Clin Oncol 16:338–341
Morrow GR (1984) The assessment of nausea and vomiting: past problems, current issues and suggestion for future research. Cancer 15 [Suppl]:2267–2280
Morrow GR (1984) Clinical characteristics associated with the development of anticipatory nausea and vom iting in cancer patients undergoing chemotherapy treatment. J Clin Oncol 2:1170–1176
Morrow GR, Dobkin PL (1988) Anticipatory nausea and vomiting in cancer patients undergoing chemo therapy treatment: prevalence, etiology, and behavioral interventions. Clin Psychol Rev 8:517–556
Osoba D (1991) Measuring the effect of cancer on quality of life. In: Osoba D (ed) Effect of cancer on quality of life. CRC Press, Boca Raton, Fla, pp 25–40
Osoba D (1994) Lessons learned from measuring health-related quality of life in oncology. J Clin Oncol 3:608–616
Osoba D, Rusthoven JJ, Turnbull KA, Evans WK, Shepherd FA (1985) Combination chemotherapy with bleomycin, etoposide, and cisplatin in metastatic non-small-cell lung cancer. J Clin Oncol 3:1478–1485
Peresson L (1980) Psicoterapia autogena. Faenza Editrice, Faenza
Pfefferbaum B, Overall JE, Boren HA, Frankel LS, Sullivan MP, Johnson K (1987) Alprazolam in the treatment of anticipatory and acute situational anxiety in children with cancer. J Am Acad Child Adolesc Psychiatry 26:532–535
Razavi D, Delvaux N, Farvacques C, et al (1993) Prevention of adjustment disorders and anticipatory nausea sec ondary to adjuvant chemotherapy: a double-blind, placebo-controlled study assessing the usefulness of alprazolam. J Clin Oncol 11:1384–1390
Schipper H, Clinch J, Mc Murray A, Levitt M (1984) Measuring the quality of life of cancer patients: the Functional Living Index-Cancer — development and validation. J Clin Oncol 2:472–483
Schultz JH (1966) Das autogene Training. Thieme, Stuttgart
Scott PJ, Huskisson EC (1976) Graphic representation of pain. Pain 2:175–184
Skeel RT (1989) Quality of life assessment in cancer clinical trials — it's time to catch up. J Natl Cancer Inst 81:472–473
Spiegel D, Bloom JR (1983) Group therapy and hypnosis reduce metastatic breast carcinoma pain. Psychosom Med 45:333–339
Spiegel D, Morrow GR, Raubertas RF, et al (1995) Multicenter trial of supportive/expressive group psychotherapy for recently diagnosed breast cancer patients: a URCC COOP study. Proc Am Soc Clin Oncol 14:506
Spielberger CD, Corsuch RL, Lushene RE (1970) STAL manual for the State-Trait Inventory. Consulting Psychologist Press, Palo Alto
Spitzer WO, Dobson AJ, Hall J, et al (1981) Measuring the quality of life of cancer patients. A concise QL-Index for use by physicians. J Chronic Dis 34:585–597
Tamburini M, Brambilla C, Ferrari L, Bombino T, Gangeri L, Rosso S (1991) Two simple indexes used to evaluate the impact of therapy on the quality of life of patients receiving primary chemotherapy for operable breast cancer. Ann Oncol 2:417–422
Tchekmedyian NS, Cella DF (eds) (1991) Quality of life in current oncology practice and research. Dominus, Williston Park, NY
Till JE (1992) Quality of life measurements in cancer treatment. In: DeVita V Jr, Hellman S, Rosenberg S (eds) Important advances in oncology 1992. Lippincott, Philadelphia, pp 189–204
US Department of Health and Human Services (DHHS), Public Health Service, National Institutes of Health (1990) Quality of life assessment in cancer clinical trials: report of the Workshop on Quality of Life Research in Cancer Clinical Trials. Prevention and control. Division of Cancer Prevention and Control, National Cancer Institute, Bethesda, Md
Watson M (1983) Psychological intervention with cancer patients. Psychol Med 13:839–846
Watson M, Greer S, Rowden L, et al (1991) Relationship between emotional control, adjustment to cancer and depression and anxiety in breast cancer patients. Psychol Med 21:51–57
Weeks J (1992) Quality-of-life assessment: performance status upstaged? J Clin Oncol 10:1827–1829
Westbrook L, Cicala RS, Writgh H (1990) Effectiveness of alprazolam in the treatment of chronic pain: results of a preliminary study. Clin J Pain 6:32–36
Wortman CB (1984) Social support and the cancer patient: conceptual and methodologic issues. Cancer 53 [Suppl 10]:2339–2360
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mantovani, G., Astara, G., Lampis, B. et al. Evaluation by multidimensional instruments of health-related quality of life of elderly cancer patients undergoing three different “psychosocial” treatment approaches. Support Care Cancer 4, 129–140 (1996). https://doi.org/10.1007/BF01845762
Issue Date:
DOI: https://doi.org/10.1007/BF01845762